Nearly 7,000 excess deaths from TB occurred in the WHO European Region in the three years of the pandemic from 2020-2022, compared to what experts had expected based on pre-2020 estimates.

A guide for affected community and civil society organizations, national TB programs and policy-makers in eastern Europe and central Asia

On World TB Day 2023, ECDC and WHO/Europe issue a sobering warning that, despite having the tools to end TB, the European Region remains a long way from meeting its End TB Strategy targets.

The European Centre for Disease Prevention and Control (ECDC) and the World Health Organization Regional Office for Europe (WHO/Europe) will host a webinar on 22 March 2023 to mark World TB Day, 'Measuring progress, moving forward towards Ending TB in Europe and Central Asia'.

7 Apr 2022: In the context of the mass influx of refugees from Ukraine into the European Union (EU), the European Economic Area (EEA) and other European countries, ECDC and the WHO Regional Office for Europe are releasing today an information note on testing for tuberculosis infection and screening for tuberculosis disease.

ECDC and WHO/Europe release a joint report providing an overview of the latest TB epidemiological situation in the WHO European Region.

On 22 April 2021, the TB Europe Coalition in partnership with the World Health Organization (WHO) Regional Office for Europe, invites civil society and TB-affected community from Eastern Europe and Central Asia countries to join a capacity building online event 'Exploring practical opportunities for civil society and TB-affected community through WHO National TB Program reviews to improve collaboration and accountability'.

TB burden in the WHO European Region as a whole is decreasing. However, TB is second only to COVID-19 as an infectious disease that kills, and drug resistance is a major concern.

The Regional Office for Europe of the World Health Organization (WHO) invites representatives of the TB affected community and civil society to apply for the WHO rosters of consultants for future possible involvement to complement the impact analysis of the TB progress at the country level through participation in National TB Program Reviews.

WHO/Europe has launched a new online course to strengthen the capacity to diagnose drug-resistant tuberculosis (DR-TB) using molecular techniques. This free course, entitled “Drug-resistant tuberculosis: how to interpret rapid molecular test results”, is available on the OpenWHO platform and includes opportunities for participants throughout the world to seek expert advice for their diagnostic questions.